A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases

Journal of Clinical Epidemiology

Volumn 78, Issue , 2016, Pages 63-72

  Wong, Carlos K H ^a   Lang, Brian H H ^a   Lam, Cindy L K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

COSMIN; Measurement property; Psychometrics; Quality of life; Systematic review; Thyroid disease

Indexed keywords

ASSESSMENT OF HUMANS; BENIGN TUMOR; ENDOCRINE OPHTHALMOPATHY; GRAVES OPHTHALMOPATHY SPECIFIC QUALITY OF LIFE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; METHODOLOGY; PATIENT-REPORTED OUTCOME; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; REVIEW; SYSTEMATIC REVIEW; THYROID CANCER; THYROID DISEASE; THYROID SPECIFIC PATIENT REPORTED OUTCOME; THYROID TREATMENT SATISFACTION QUESTIONNAIRE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; THYROID DISEASES;

HUMANS; PATIENT OUTCOME ASSESSMENT; PATIENT SATISFACTION; PSYCHOMETRICS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; THYROID DISEASES;

EID: 84964211322     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.03.006     Document Type: Review

References (53)

1. [1] Madariaga, A.G., Palacios, S.S., Guillén-Grima, F., Galofré, J.C., The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 99 (2014), 923–931.
2. [2] Morris, L.G.T., Sikora, A.G., Tosteson, T.D., Davies, L., The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23 (2013), 885–891.
3. [3] Lang, B.H.H., Wong, C.K., Chan, C.T., Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: a health care service provider perspective. Eur J Surg Oncol 41 (2015), 758–765.
4. [4] Leese, G.P., Flynn, R.V., Jung, R.T., MacDonald, T.M., Murphy, M.J., Morris, A.D., Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin Endocrinol 68 (2008), 311–316.
5. [5] Links, T.P., van Tol, K.M., Jager, P.L., Plukker, J.T.M., Piers, D.A., Boezen, H.M., et al. Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 12 (2005), 273–280.
6. [6] Wilson, I.B., Cleary, P.D., Linking clinical variables with health-related quality of life. JAMA 273 (1995), 59–65.
7. [7] Dow, K.H., Ferrell, B.R., Anello, C., Quality-of-Life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 7 (1997), 613–619.
8. [8] Razvi, S., McMillan, C.V., Weaver, J.U., Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: a systematic qualitative review. Clin Endocrinol 63 (2005), 617–624.
9. [9] Watt, T., Groenvold, M., Rasmussen, A.K., Bonnema, S.J., Hegedus, L., Bjorner, J.B., et al. Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol 154 (2006), 501–510.
10. [10] Husson, O., Haak, H.R., Oranje, W.A., Mols, F., Reemst, P.H., van de Poll-Franse, L.V., Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol 75 (2011), 544–554.
11. [11] Elberling, T., Rasmussen, A., Feldt-Rasmussen, U., Hording, M., Perrild, H., Waldemar, G., Impaired health-related quality of life in Graves' disease. A prospective study. Eur J Endocrinol 151 (2004), 549–555.
12. [12] Terwee, C.B., Bot, S.D., de Boer, M.R., van der Windt, D.A., Knol, D.L., Dekker, J., et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60 (2007), 34–42.
13. [13] Terwee, C.B., Mokkink, L.B., Knol, D.L., Ostelo, R.W., Bouter, L.M., de Vet, H.C., Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 21 (2012), 651–657.
14. [14] Jaeschke, R., Guyatt, G., Cook, D., Harper, S., Gerstein, H.C., Spectrum of quality of life impairment in hypothyroidism. Qual Life Res 3 (1994), 323–327.
15. [15] Mokkink, L.B., Terwee, C.B., Patrick, D.L., Alonso, J., Stratford, P.W., Knol, D.L., et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 63 (2010), 737–745.
16. [16] Mokkink, L.B., Terwee, C.B., Patrick, D.L., Alonso, J., Stratford, P.W., Knol, D.L., et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 19 (2010), 539–549.
17. [17] Mokkink, L., Terwee, C., Knol, D., Stratford, P., Alonso, J., Patrick, D., et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol, 10, 2010, 22.
18. [18] Luckett, T., King, M.T., Butow, P.N., Oguchi, M., Rankin, N., Price, M.A., et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 22 (2011), 2179–2190.
19. [19] Wong, C.K.H., Chen, J., Yu, C.L.Y., Sham, M., Lam, C.L.K., Systematic review recommends the European Organization for Research and Treatment of Cancer colorectal cancer–specific module for measuring quality of life in colorectal cancer patients. J Clin Epidemiol 68 (2015), 266–278.
20. [20] Wheelwright, S., Darlington, A.-S., Hopkinson, J., Fitzsimmons, D., White, A., Johnson, C., A systematic review of health-related quality of life instruments in patients with cancer cachexia. Support Care Cancer 21 (2013), 2625–2636.
21. [21] Pusic, A., Cemal, Y., Albornoz, C., Klassen, A., Cano, S., Sulimanoff, I., et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv 7 (2013), 83–92.
22. [22] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62 (2009), 1006–1012.
23. [23] Carrillo, J.F., Ortiz-Toledo, M.A., Salido-Noriega, Z., Romero-Ventura, N.B., Ochoa-Carrillo, F.J., Onate-Ocana, L.F., Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers. Ann Surg Oncol 20 (2013), 1417–1426.
24. [24] Watt, T., Rasmussen, A.K., Groenvold, M., Bjorner, J.B., Watt, S.H., Bonnema, S.J., et al. Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing. Qual Life Res 17 (2008), 1009–1017.
25. [25] Watt, T., Bjorner, J.B., Groenvold, M., Rasmussen, A.K., Bonnema, S.J., Hegedus, L., et al. Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination. Qual Life Res 18 (2009), 483–496.
26. [26] Watt, T., Hegedus, L., Groenvold, M., Bjorner, J.B., Rasmussen, A.K., Bonnema, S.J., et al. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol 162 (2010), 161–167.
27. [27] Watt, T., Cramon, P., Hegedus, L., Bjorner, J.B., Bonnema, S.J., Rasmussen, A.K., et al. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab 99 (2014), 3708–3717.
28. [28] Watt, T., Groenvold, M., Deng, N., Gandek, B., Feldt-Rasmussen, U., Rasmussen, A.K., et al. Confirmatory factor analysis of the thyroid-related quality of life questionnaire ThyPRO. Health Qual Life Outcomes, 12, 2014, 126.
29. [29] Watt, T., Groenvold, M., Hegedus, L., Bonnema, S.J., Rasmussen, A.K., Feldt-Rasmussen, U., et al. Few items in the thyroid-related quality of life instrument ThyPRO exhibited differential item functioning. Qual Life Res 23 (2014), 327–338.
30. [30] Terwee, C.B., Gerding, M.N., Dekker, F.W., Prummel, M.F., Wiersinga, W.M., Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol 82 (1998), 773–779.
31. [31] Terwee, C.B., Gerding, M.N., Dekker, F.W., Prummel, M.F., van der Pol, J.P., Wiersinga, W.M., Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy. J Clin Epidemiol 52 (1999), 875–884.
32. [32] Terwee, C.B., Dekker, F.W., Mourits, M.P., Gerding, M.N., Baldeschi, L., Kalmann, R., et al. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol 54 (2001), 391–398.
33. [33] Choi, Y.J., Lim, H.T., Lee, S.J., Lee, S.Y., Yoon, J.S., Assessing Graves' ophthalmopathy-specific quality of life in Korean patients. Eye (Lond) 26 (2012), 544–551.
34. [34] McMillan, C.V., Bradley, C., Woodcock, A., Razvi, S., Weaver, J.U., Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid 14 (2004), 916–925.
35. [35] McMillan, C., Bradley, C., Razvi, S., Weaver, J., Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ. Value Health 11 (2008), 285–294.
36. [36] Quinque, E.M., Villringer, A., Kratzsch, J., Karger, S., Patient-reported outcomes in adequately treated hypothyroidism—insights from the German versions of ThyDQoL, ThySRQ and ThyTSQ. Health Qual Life Outcomes, 11, 2013, 68.
37. [37] McMillan, C., Bradley, C., Razvi, S., Weaver, J., Psychometric evaluation of a new questionnaire measuring treatment satisfaction in hypothyroidism: the ThyTSQ. Value Health 9 (2006), 132–139.
38. [38] Fahrenfort, J.J., Wilterdink, A.M., van der Veen, E.A., Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology 25 (2000), 201–211.
39. [39] Abdul-Sater, L., Henry, M., Majdan, A., Mijovic, T., Franklin, J.H., Brandt, M.G., et al. What are thyroidectomy patients really concerned about?. Otolaryngol Head Neck Surg 144 (2011), 685–690.
40. [40] Patrick Yeatts, R., Quality of life in patients with graves ophthalmopathy. Trans Am Ophthalmol Soc 103 (2005), 368–411.
41. [41] Bradley, E.A., Sloan, J.A., Novotny, P.J., Garrity, J.A., Woog, J.J., West, S.K., Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy. Ophthalmology 113 (2006), 1450–1454.
42. [42] Fayers, T., Dolman, P.J., Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease. Br J Ophthalmol 95 (2011), 1670–1674.
43. [43] Son, B.J., Lee, S.Y., Yoon, J.S., Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients. Can J Ophthalmol 49 (2014), 167–173.
44. [44] Gning, I., Trask, P.C., Mendoza, T.R., Harle, M.T., Gutierrez, K.A., Kitaka, S.A., et al. Development and initial validation of the thyroid Cancer module of the M. D. Anderson symptom Inventory. Oncology 76 (2009), 59–68.
45. [45] Husson, O., Haak, H.R., Mols, F., Nieuwenhuijzen, G.A., Nieuwlaat, W.A., Reemst, P.H., et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol 52 (2013), 447–454.
46. [46] Watt, T., Barbesino, G., Bjorner, J., Bonnema, S., Bukvic, B., Drummond, R., et al. Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Qual Life Res 24 (2015), 769–780.
47. [47] Watt, T., Bjorner, J.B., Groenvold, M., Cramon, P., Winther, K.H., Hegedüs, L., et al. Development of a short version of the thyroid-related patient-reported outcome ThyPRO. Thyroid 25 (2015), 1069–1079.
48. [48] Chow, S.M., Au, K.H., Choy, T.S., Lee, S.H., Yeung, N.Y., Leung, A., et al. Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdrawal for whole body scanning. Laryngoscope 116 (2006), 2060–2066.
49. [49] Taieb, D., Baumstarck-Barrau, K., Sebag, F., Fortanier, C., De Micco, C., Loundou, A., et al. Heath-related quality of life in thyroid cancer patients following radioiodine ablation. Health Qual Life Outcomes, 9, 2011, 33.
50. [50] Cella, D., Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. 1997, Center on Outcomes, Research & Education (CORE), Evanston Northwestern Healthcare and Northwestern University, Evanston IL Version 4.
51. [51] FACIT.org. FACIT Questionnaires. 2015 Available at: http://www.facit.org/FACITOrg/Questionnaires.
52. [52] EORTC QOL Module for Thyroid Cancer (QLQ-THY). EORTC Quality of Life Department. Available at: http://groups.eortc.be/qol/eortc-qol-module-thyroid-cancer-qlq-thy.
53. [53] Singer, S., Araújo, C., Arraras, J.I., Baumann, I., Boehm, A., Brokstad Herlofson, B., et al. Measuring quality of life in patients with head and neck cancer: update of the EORTC QLQ-H&N Module, Phase III. Head Neck 37 (2015), 1358–1367.